• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国纽约威尔康奈尔医学院将超声作为游离胎儿DNA非整倍体筛查潜在辅助手段的应用

The Use of Ultrasound as a Potential Adjunct to Cell-Free Fetal DNA Screening for Aneuploidy at Weill Cornell Medical College, New York, USA.

作者信息

Scholl Jessica, Chasen Stephen

机构信息

Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, New York.

出版信息

Surg J (N Y). 2018 Feb 9;4(1):e1-e6. doi: 10.1055/s-0038-1624564. eCollection 2018 Jan.

DOI:10.1055/s-0038-1624564
PMID:29435489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5807075/
Abstract

To evaluate the utility of ultrasound in identifying fetuses with uncommon chromosomal abnormalities that would be considered not detectable by cell-free fetal deoxyribonucleic acid (cfDNA).  We performed a retrospective study of fetuses with chromosomal abnormalities that would be undetectable by cfDNA, who underwent an 11- to 14-week ultrasound from 2006 to 2016.  There were 43 pregnancies included. First-trimester ultrasound revealed a fetal abnormality in 19 (44.2%) cases, of which 13 (30.2%) had a thickened nuchal translucency. There were an additional four fetuses with second-trimester sonographic abnormalities. Overall, 23 (53.5%) fetuses were found to have a major anomaly diagnosed by ultrasound. The rate of first-trimester sonographic abnormalities varied widely based on category of chromosomal abnormalities with high rates seen with triploidy (87.5%) and autosomal trisomy (80%) and lower rates seen with structurally abnormal chromosomes (33.3%), trisomy mosaicism (27.3%), other forms of mosaicism (11.1%), and deletions or duplications (25.0%),  < 0.001.  The majority of fetuses with uncommon chromosomal abnormalities in our cohort had major sonographic anomalies. The use of first-trimester ultrasound with nuchal translucency measurement may offer utility in identifying fetuses with risk of aneuploidy that would not be detectable with cfDNA.

摘要

评估超声在识别患有罕见染色体异常胎儿方面的效用,这些异常被认为无法通过游离胎儿脱氧核糖核酸(cfDNA)检测到。我们对2006年至2016年间接受11至14周超声检查、患有cfDNA无法检测到的染色体异常的胎儿进行了一项回顾性研究。纳入43例妊娠。孕早期超声检查发现19例(44.2%)胎儿有异常,其中13例(30.2%)颈部透明带增厚。另外有4例胎儿在孕中期超声检查时有异常。总体而言,23例(53.5%)胎儿经超声诊断有重大异常。孕早期超声异常率因染色体异常类型而异,三倍体(87.5%)和常染色体三体(80%)的异常率较高,而结构异常染色体(33.3%)、三体嵌合体(27.3%)、其他形式的嵌合体(11.1%)以及缺失或重复(25.0%)的异常率较低,P<0.001。我们队列中大多数患有罕见染色体异常的胎儿有重大超声异常。使用孕早期超声测量颈部透明带可能有助于识别cfDNA无法检测到的非整倍体风险胎儿。

相似文献

1
The Use of Ultrasound as a Potential Adjunct to Cell-Free Fetal DNA Screening for Aneuploidy at Weill Cornell Medical College, New York, USA.美国纽约威尔康奈尔医学院将超声作为游离胎儿DNA非整倍体筛查潜在辅助手段的应用
Surg J (N Y). 2018 Feb 9;4(1):e1-e6. doi: 10.1055/s-0038-1624564. eCollection 2018 Jan.
2
Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?在胎儿颈项透明层增厚的妊娠中是否应该使用游离 DNA 检测?
Ultrasound Obstet Gynecol. 2020 May;55(5):645-651. doi: 10.1002/uog.20397. Epub 2020 Apr 7.
3
Prenatal screening for fetal aneuploidy in singleton pregnancies.单胎妊娠胎儿非整倍体的产前筛查。
J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1.
4
[Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].孕早期胎儿颈部透明带与妊娠结局的前瞻性队列研究
Zhonghua Fu Chan Ke Za Zhi. 2020 Feb 25;55(2):94-99. doi: 10.3760/cma.j.issn.0529-567X.2020.02.007.
5
Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester: (Replaces Consults #10, Single umbilical artery, October 2010; #16, Isolated echogenic bowel diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation and management of isolated renal pelviectasis on second-trimester ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts, April 2013; #27, Isolated echogenic intracardiac focus, August 2013).母胎医学会咨询系列第 57 号:中孕期单纯性软指标超声标记物用于染色体非整倍体的评估与管理:(取代咨询 10 号:单脐动脉,2010 年 10 月;咨询 16 号:中孕期超声诊断孤立性肠回声增强,2011 年 8 月;咨询 17 号:中孕期超声检查孤立性肾盂扩张的评估与管理,2011 年 12 月;咨询 25 号:孤立性胎儿脉络丛囊肿,2013 年 4 月;咨询 27 号:孤立性心内强回声灶,2013 年 8 月)。
Am J Obstet Gynecol. 2021 Oct;225(4):B2-B15. doi: 10.1016/j.ajog.2021.06.079. Epub 2021 Jun 23.
6
Reexamining the optimal nuchal translucency cutoff for diagnostic testing in the cell-free DNA and microarray era: results from the Victorian Perinatal Record Linkage study.重新审视细胞游离 DNA 和微阵列时代诊断检测的最佳颈项透明层截断值:来自维多利亚围产期记录链接研究的结果。
Am J Obstet Gynecol. 2021 Nov;225(5):527.e1-527.e12. doi: 10.1016/j.ajog.2021.03.050. Epub 2021 May 3.
7
[Investigation of ultrasound markers in screening fetal trisomy 21].[超声标志物在筛查胎儿21三体中的研究]
Zhonghua Fu Chan Ke Za Zhi. 2013 Feb;48(2):81-5.
8
Incidence of chromosomal abnormalities in fetuses with first trimester ultrasound anomalies and a low-risk cell-free DNA test for common trisomies.早孕期超声异常且常见三体综合征游离 DNA 检测风险低的胎儿的染色体异常发生率。
Prenat Diagn. 2020 Oct;40(11):1474-1481. doi: 10.1002/pd.5799. Epub 2020 Aug 9.
9
First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.通过详细的早期异常扫描进行孕早期18三体、13三体、三倍体和特纳综合征的筛查。
Ultrasound Obstet Gynecol. 2016 Oct;48(4):446-451. doi: 10.1002/uog.15829.
10
Diagnosis and management of fetal nuchal translucency.胎儿颈部透明带的诊断与管理
Semin Roentgenol. 1998 Oct;33(4):333-8. doi: 10.1016/s0037-198x(98)80040-0.

本文引用的文献

1
ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice.国际妇产科超声学会(ISUOG)关于cfDNA非整倍体检测对筛查策略和产前超声实践影响的更新共识声明。
Ultrasound Obstet Gynecol. 2017 Jun;49(6):815-816. doi: 10.1002/uog.17483.
2
Committee Opinion No 700: Methods for Estimating the Due Date.委员会意见 700:预产期估计方法。
Obstet Gynecol. 2017 May;129(5):e150-e154. doi: 10.1097/AOG.0000000000002046.
3
The role of ultrasound in women who undergo cell-free DNA screening.超声检查在游离 DNA 筛查女性中的作用。
Am J Obstet Gynecol. 2017 Mar;216(3):B2-B7. doi: 10.1016/j.ajog.2017.01.005. Epub 2017 Jan 17.
4
The value of the first trimester ultrasound in the era of cell free DNA screening.游离DNA筛查时代孕早期超声检查的价值
Prenat Diagn. 2016 Dec;36(13):1192-1198. doi: 10.1002/pd.4955. Epub 2016 Dec 2.
5
Women should decide which conditions matter.女性应该决定哪些情况至关重要。
Am J Obstet Gynecol. 2016 Nov;215(5):583-587.e1. doi: 10.1016/j.ajog.2016.06.045.
6
Practice Bulletin No. 163: Screening for Fetal Aneuploidy.实践通报第 163 号:胎儿非整倍体筛查。
Obstet Gynecol. 2016 May;127(5):e123-e137. doi: 10.1097/AOG.0000000000001406.
7
What is the role of the 11- to 14-week ultrasound in women with negative cell-free DNA screening for aneuploidy?对于非整倍体游离DNA筛查结果为阴性的女性,孕11至14周超声检查有何作用?
Prenat Diagn. 2016 Mar;36(3):260-5. doi: 10.1002/pd.4774. Epub 2016 Feb 5.
8
Chromosomal abnormalities not currently detected by cell-free fetal DNA: a retrospective analysis at a single center.目前无法通过游离胎儿 DNA 检测到的染色体异常:单中心回顾性分析。
Am J Obstet Gynecol. 2016 Jun;214(6):729.e1-729.e11. doi: 10.1016/j.ajog.2015.12.025. Epub 2015 Dec 22.
9
Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities.游离胎儿 DNA 检测与序贯筛查在胎儿染色体异常检测中的应用比较。
Am J Obstet Gynecol. 2016 Jun;214(6):727.e1-6. doi: 10.1016/j.ajog.2015.12.018. Epub 2015 Dec 18.
10
Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.第640号委员会意见:游离DNA筛查胎儿非整倍体。
Obstet Gynecol. 2015 Sep;126(3):e31-e37. doi: 10.1097/AOG.0000000000001051.